Prinz B, Plewig G
Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, München.
Hautarzt. 1994 Nov;45(11):746-50. doi: 10.1007/s001050050164.
Extracorporeal photopheresis is a new therapeutic approach developed by Edelson et al.; it is conceptually designed for the management of diseases mediated by malignant lymphocyte pathology, such as cutaneous T-cell-lymphoma (CTCL), and other disorders mediated by aberrant lymphocyte function, e.g. autoimmune diseases. The treatment is described in this paper, and theories on the mechanisms of action are discussed. In addition, the indications for treatment with extracorporeal photopheresis are discussed.
体外光化学疗法是由埃德尔森等人开发的一种新的治疗方法；从概念上讲，它是为治疗由恶性淋巴细胞病变介导的疾病而设计的，如皮肤T细胞淋巴瘤（CTCL），以及由异常淋巴细胞功能介导的其他疾病，如自身免疫性疾病。本文描述了该治疗方法，并讨论了其作用机制的相关理论。此外，还讨论了体外光化学疗法的治疗适应症。
